Inventor · disambiguated record
Anke Baum
Also filed as: BAUM ANKE
19 granted patents·30 pending applications·517 citations·filing 2001–2024
96Inventor score
Files withBOEHRINGER INGELHEIM INT22BOEHRINGER INGELHEIM PHARMA12SOLCA FLAVIO4GSCHWIND ANDREAS2HIMMELSBACH FRANK2
Top patents by PatentIndex Score
49 records- 0197USRE43431EQuinazoline derivatives and pharmaceutical compositions containing themHIMMELSBACH FRANK·Filed 2009·Granted May 29, 2012·37 cites·12 claims
- 0297US7750152B2Intermediate compounds for making dihydropteridinones useful as pharmaceutical compositions and processes of making the sameBOEHRINGER INGELHEIM PHARMA·Filed 2007·Granted Jul 6, 2010·47 cites·12 claims
- 0397US6861422B2Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Mar 1, 2005·115 cites·8 claims
- 0496US8003786B2Dihydropteridinone compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2010·Granted Aug 23, 2011·34 cites·1 claims
- 0596US7846936B2Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesisBOEHRINGER INGELHEIM INT·Filed 2008·Granted Dec 7, 2010·42 cites·5 claims
- 0696US7786299B2Methods for treating diseases or conditions using dihydropteridinone compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2005·Granted Aug 31, 2010·19 cites·14 claims
- 0796US7019012B2Quinazoline derivatives and pharmaceutical compositions containing themBOEHRINGER INGELHEIM INT·Filed 2001·Granted Mar 28, 2006·64 cites·6 claims
- 0895US7220750B2Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing themBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted May 22, 2007·71 cites·9 claims
- 0992US7521457B2Pyrimidines as PLK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2005·Granted Apr 21, 2009·27 cites·11 claims
- 1089US8404697B2Quinazoline derivatives for the treatment of cancer diseasesSOLCA FLAVIO·Filed 2006·Granted Mar 26, 2013·14 cites·2 claims
- 1187US8143247B2Combinations for the treatment of diseases involving cell proliferationMUNZERT GERD·Filed 2009·Granted Mar 27, 2012·13 cites·11 claims
- 1286US7569561B22,4-diaminopyrimidines useful for treating cell proliferation diseasesBOEHRINGER INGELHEIM INT·Filed 2007·Granted Aug 4, 2009·11 cites·8 claims
- 1385US8992915B2Combination of CD37 antibodies with ICEHEIDER KARL-HEINZ·Filed 2013·Granted Mar 31, 2015·15 cites·23 claims
- 1480US9539258B2Quinazoline derivatives for the treatment of cancer diseasesBOEHRINGER INGELHEIM INT·Filed 2015·Granted Jan 10, 2017·2 cites·5 claims
- 1579US9089571B2Quinazoline derivatives for the treatment of cancer diseasesSOLCA FLAVIO·Filed 2013·Granted Jul 28, 2015·3 cites·3 claims
- 1677US8586608B2Quinazoline derivatives and pharmaceutical compositions containing themBOEHRINGER INGELHEIM PHARMA·Filed 2009·Granted Nov 19, 2013·1 cites·3 claims
- 1771US8722694B2Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing themHIMMELSBACH FRANK·Filed 2012·Granted May 13, 2014·1 cites·9 claims
- 1869US2025228858A1Anti-cancer combination therapyBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1968US8591895B2Combinations for the treatment of diseases involving cell proliferationMUNZERT GERD·Filed 2012·Granted Nov 26, 2013·1 cites·18 claims
- 2068US2010069414A1Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing themBOEHRINGER INGELHEIM PHARMA·Filed 2009·Application pending·0 cites
- 2164US2009163465A1Pyrimidines as PLK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2009·Application pending·0 cites
- 2264US2009149438A1Pyrimidines as PLK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2009·Application pending·0 cites
- 2362US2014057898A1Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesisSTEFANIC MARTIN FRIEDRICH·Filed 2013·Application pending·0 cites
- 2461US2007185091A1Bicyclic Heterocycles, Pharmaceutical Compositions Containing These Compounds, Their Use and Processes for Preparing ThemBOEHRINGER INGELHEIM PHARMA·Filed 2007·Application pending·0 cites
- 2560US2025205238A1Anti-cancer combination therapyBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 2660US2018360834A1Quinazoline derivatives for the treatment of cancer diseasesBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 2760US2005014760A1Methods of treating diseases or conditions using dihydropteridinone compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2004·Application pending·0 cites
- 2859US11814380B2Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2020·Granted Nov 14, 2023·0 cites·14 claims
- 2959US2006100223A1Quinazoline derivatives and pharmaceutical compositions containing themBOEHRINGER INGELHEIM PHARMA·Filed 2005·Application pending·0 cites
- 3059US2005014761A1Intermediate compounds for making dihydropteridinones useful as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2004·Application pending·0 cites
- 3158US2005043233A1Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesisBOEHRINGER INGELHEIM INT·Filed 2004·Application pending·0 cites
- 3257US2011039863A1Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesisBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
- 3357US2004126379A1Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and chemotherapeutic agentsBOEHRINGER INGELHEIM INT·Filed 2003·Application pending·0 cites
- 3457US2017112835A1Quinazoline derivatives for the treatment of cancer diseasesBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
- 3557US2011136826A1Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesisBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
- 3656US2015265610A1Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesisBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 3756US2011171289A1Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesisBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
- 3855US2011046168A1Methods of treating diseases using quinazoline derivatives and pharmaceutical compositions containing themBOEHRINGER INGELHEIM PHARMA·Filed 2010·Application pending·0 cites
- 3955US2009306101A1Combination treatment of cancer comprising egfr/her2 inhibitorsSOLCA FLAVIO·Filed 2006·Application pending·0 cites
- 4055US2014199298A1Combination treatment of cancer comprising egfr/her2 inhibitorsSOLCA FLAVIO·Filed 2014·Application pending·0 cites
- 4155US2005244413A1Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and chemotherapeutic agentsADOLF GUENTHER·Filed 2005·Application pending·0 cites
- 4254US2018086744A1Combination treatment of cancer comprising egfr/her2 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 4353US2006058311A1Combinations for the treatment of diseases involving cell proliferationBOEHRINGER INGELHEIM INT·Filed 2005·Application pending·0 cites
- 4452US2011086842A1Pyrimidines as PLK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
- 4550US2021038602A1Combination treatment of acute myeloid leukemiaBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 4639US2014018372A1Crystalline form of a indolinone derivative and its useMAIER GERD-MICHAEL·Filed 2013·Application pending·0 cites
- 4738US2014093499A1Pharmaceutical combinations comprising dual angiopoietin-2 / dll4 binders and anti-vegf agentsGSCHWIND ANDREAS·Filed 2013·Application pending·0 cites
- 4838US2014093498A1Pharmaceutical combinations comprising dual angiopoietin-2 / dll4 binders and anti-vegf-r agentsGSCHWIND ANDREAS·Filed 2013·Application pending·0 cites
- 4933US2012157472A1Method for treating colorectal cancerLARSEN ANNETTE·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anke Baum files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →